Efficacy and safety of Bufei Huoxue capsules in the management of convalescent patients with COVID-19 infection: A multicentre, double-blind, and randomised controlled trial

BACKGROUND: As of September 17, 2021, coronavirus disease 2019 (COVID-19) has infected more than 226 million people in a worldwide pandemic, with conservative estimates suggesting that there are more than 204 million convalescent patients with COVID-19. Previous studies have indicated that patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yuqin, Liu, Chunli, Wang, Tingping, Qi, Jingjing, Jia, Xiaoqing, Zeng, Xiansheng, Bai, Jianling, Lu, Wenju, Deng, Yu, Zhong, Bihua, He, Wenjun, Xing, Yue, Lian, Zhan, Zhou, Haohao, Yan, Junping, Yang, Xuejiao, Yu, Hao, Zhou, Jiawei, Zhou, Dansha, Qiu, Lixia, Zhong, Nanshan, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575540/
https://www.ncbi.nlm.nih.gov/pubmed/34763045
http://dx.doi.org/10.1016/j.jep.2021.114830

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575540/
https://www.ncbi.nlm.nih.gov/pubmed/34763045
http://dx.doi.org/10.1016/j.jep.2021.114830

Ejemplares similares